All About CARVYKTI for Multiple Myeloma
All About CARVYKTI for Multiple Myeloma image
All About CARVYKTI for Multiple Myeloma
Posted May 27, 2022


What is CARVYKTI? CARVYKTI is a CAR-T cell therapy that was recently approved. Find out below all about how CARVYKTI works.

7.19    All About CARVYKTI


We’d like to thank our faculty who donated their time in creating these videos, including:

  • Peter Voorhees, MD
  • Adam Cohen, MD

Want more?

We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!


The author Cynthia Chmielewski

about the author
Cynthia Chmielewski

Cynthia Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University.

More HealthTree University Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Bristol Myers Squibb
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811